# Effect of Exercise and/or Liraglutide on Vascular Dysfunction and Insulin Sensitivity in Type 2 Diabetes ( ZQL007)

> **NCT03883412** · PHASE4 · UNKNOWN · sponsor: **University of Virginia** · enrollment: 60 (estimated)

## Conditions studied

- Type2 Diabetes

## Interventions

- **OTHER:** Exercise
- **DRUG:** Liraglutide

## Key facts

- **NCT ID:** NCT03883412
- **Lead sponsor:** University of Virginia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-02-28
- **Primary completion:** 2025-06
- **Final completion:** 2025-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-12-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03883412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03883412, "Effect of Exercise and/or Liraglutide on Vascular Dysfunction and Insulin Sensitivity in Type 2 Diabetes ( ZQL007)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03883412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*